Gyre Therapeutics Inc. (GYRE)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
779,348,000
EV to revenue ratio (TTM)
6.51
EV to ebitda
131
Financial Performance
Revenue (TTM)
109,818,000
Gross profit (TTM)
103,011,000
EBITDA
-12,131,000
Profitability
Operating margin (TTM)
-47.60%
Profit margin
-19.30%
Return on assets (TTM)
-5.42%
Return on equity (TTM)
-17.40%
Per Share Metrics
Revenue per share (TTM)
1.17
EPS
-0.21
Diluted EPS (TTM)
-0.21
Book value
1.02
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
188.68
PEG ratio
Price to sales ratio (TTM)
7.1
Price to book ratio (TTM)
7.28
Growth
Quarterly earnings growth (YoY)
-2.10%
Quarterly revenue growth (YoY)
166.20%
Analyst Sentiment
Strong buy
0
Buy
3
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
4.828